SCI
4September
PietanzaMC,WaqarSN,KrugLM,etal.Randomized,Double-Blind,PhaseIIStudyofTemozolomideinCombinationWithEitherVelipariborPlaceboinPatientsWithRelapsed-SensitiveorRefractorySmall-CellLungCancer.JClinOncol;36:-.
CorrespondingAuthor:
LaurenAverettByers,MD,DepartmentofThoracic/HeadandNeckMedicalOncology,TheUniversityofTexasMDAndersonCancerCenter,Hol